Skip to main content
Roland Pharma Roland Pharma Get a Free Consultation
Roland Pharma
08

Clinical Study Support

Scientific and regulatory support for clinical investigations evaluating the safety, effectiveness and behaviour of medicines in humans.

Phase I–IV GCP Compliance Pharmacokinetics
Overview

Regulatory and Operational Support Across the Study Lifecycle

A clinical study is a scientific investigation in humans, designed to evaluate how a medicine behaves — and to generate evidence that will withstand regulatory scrutiny years later. We support sponsors and sites with the compliance layer that surrounds that science.

Our involvement spans protocol and documentation review, site readiness, GCP compliance and the quality oversight that keeps a study inspection-ready throughout.

At a Glance

  • Safety, efficacy and dosage evaluation
  • Phase I–IV study support
  • Pharmacokinetic assessment

Need this scoped for your facility and target market? A senior consultant will give you a candid read at no cost.

Request a Proposal

What Clinical Studies Evaluate

Four dimensions assessed across the development programme.

Safety

Identification and characterisation of side effects, adverse events and the overall risk profile.

Efficacy

How effectively the medicine treats or prevents the condition under investigation.

Dosage

Determination of the optimal dose delivering therapeutic benefit at minimal risk.

Pharmacokinetics

How the medicine is absorbed, distributed, metabolised and eliminated by the body.

The Four Clinical Study Phases

From first-in-human through to post-marketing surveillance.

01

Phase I — Safety & Dosage

First administration in small groups of healthy volunteers or patients, establishing safety, tolerability and dose range.

02

Phase II — Effectiveness

Therapeutic evaluation in a larger patient group, refining dose and generating initial efficacy evidence.

03

Phase III — Large-Scale Trials

Confirmatory studies in large populations, typically comparing against standard treatment or placebo.

04

Phase IV — Post-Marketing

Long-term monitoring after authorisation, capturing rare events and real-world effectiveness.

Next Step

Ready to Transform Your GxP Strategy?

Book a no-obligation consultation and get practical answers about clinical study support for your specific product, facility and target market.